Vegafarma Turmeric Max 500ml

Liposomes are the first substance delivery system to be successfully applied in clinical practice, and these closed bilipid vesicles have undergone several technological advances over the last 55 years of existence.

Liposomes are spherical vesicles, characterised by a phospholipid bilayer with an aqueous internal cavity. Structurally, their components are phospholipids or amphipathic molecules incorporated with sterols (such as cholesterol) to influence membrane permeability.

Therapeutic delivery by liposomes alters the biodistribution profile and enhances the therapeutic action of various substances. The advantages of using this methodology are diverse and include:

• Increased efficacy and therapeutic/absorption rate.
• Increased stability through encapsulation.
• Non-toxic, flexible, biocompatible, fully biodegradable and non-immunogenic, whether administered systemically or non-systemically.
• Reduces the toxicity of encapsulated agents.
• Reduces exposure to potential harmful/toxic effects on sensitive tissues.
• Avoid local effect.
  They have flexibility with specific binders, which allows them to reach specific targets.
• Liposomes are the most common and best researched nanocarriers for therapeutic delivery.

Vegafarma Turmeric Max 500ml contains Curcuma longa which helps relieve joint pain by reducing the inflammatory response to stress and injury, while acting as an antioxidant. It is an excellent anti-inflammatory and can be used in any inflammatory condition (chronic or acute), with a high safety profile and results.

Taking supplements containing curcumin can reduce C-reactive protein levels. It features a 95% curcuminoid extract in liposomal form. This form exponentially increases the absorption/bioavailability and thus the efficacy of this diarylheptanoid (curcumin). Studies of this liposomal form of distribution show an increase of up to 1500% in the bioavailability of the product.